{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:56:11Z","timestamp":1791140171920,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81172257"],"award-info":[{"award-number":["81172257"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Xi'an Fundamental Research Funds of China","award":["HM1117-4"],"award-info":[{"award-number":["HM1117-4"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["RO1-CA90853"],"award-info":[{"award-number":["RO1-CA90853"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Texas MD Anderson Cancer Center Support Grant","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}]}],"content-domain":{"domain":["bloodreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.blre.2013.08.002","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T05:46:46Z","timestamp":1378100806000},"page":"261-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention"],"prefix":"10.1016","volume":"27","author":[{"given":"Fuling","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanjin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois X.","family":"Claret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2013.08.002_bb0005","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2013.08.002_bb0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM200407083510223","article-title":"Bone lesions in molecular subtypes of multiple myeloma","volume":"351","author":"Robbiani","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2013.08.002_bb0015","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1038\/sj.onc.1210054","article-title":"Function and biological roles of the Dickkopf family of Wnt modulators","volume":"25","author":"Niehrs","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2013.08.002_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0609.2008.01164.x","article-title":"Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment","volume":"82","author":"Heider","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2013.08.002_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2011-07-368472","article-title":"Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma","volume":"119","author":"Qian","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.08.002_bb0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","article-title":"Wnt signalling and its impact on development and cancer","volume":"8","author":"Klaus","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.blre.2013.08.002_bb0035","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2013.08.002_bb0040","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1182\/blood-2004-12-4940","article-title":"Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2","volume":"106","author":"Oshima","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.08.002_bb0045","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1182\/blood-2007-03-077685","article-title":"Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo","volume":"111","author":"Edwards","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.08.002_bb0050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jcb.21151","article-title":"VDR-mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells","volume":"101","author":"Cianferotti","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.blre.2013.08.002_bb0055","doi-asserted-by":"crossref","first-page":"19465","DOI":"10.1074\/jbc.274.27.19465","article-title":"Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling","volume":"274","author":"Fedi","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2013.08.002_bb0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/34848","article-title":"Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction","volume":"391","author":"Glinka","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.blre.2013.08.002_bb0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1534-5807(01)00041-7","article-title":"Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse","volume":"1","author":"Mukhopadhyay","year":"2001","journal-title":"Dev Cell"},{"key":"10.1016\/j.blre.2013.08.002_bb0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1101\/gad.1279405","article-title":"Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex","volume":"19","author":"Foley","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.blre.2013.08.002_bb0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bone.2007.05.009","article-title":"Bone mass is inversely proportional to Dkk1 levels in mice","volume":"41","author":"MacDonald","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.blre.2013.08.002_bb0080","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.2249","article-title":"Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture","volume":"44","author":"Estrada","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.blre.2013.08.002_bb0085","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrrheum.2012.189","article-title":"Rheumatoid arthritis: genetic variants in DKK1 linked to severity of joint damage in RA","volume":"8","author":"Buckland","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.blre.2013.08.002_bb0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/35077108","article-title":"LDL-receptor-related protein 6 is a receptor for Dickkopf proteins","volume":"411","author":"Mao","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.blre.2013.08.002_bb0095","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/nsmb.2139","article-title":"Crystal structures of the extracellular domain of LRP6 and its complex with DKK1","volume":"18","author":"Cheng","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.blre.2013.08.002_bb0100","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature756","article-title":"Kremen proteins are Dickkopf receptors that regulate Wnt\/beta-catenin signalling","volume":"417","author":"Mao","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.blre.2013.08.002_bb0105","doi-asserted-by":"crossref","first-page":"pe10","DOI":"10.1126\/stke.18pe10","article-title":"Context-dependent activation or inhibition of Wnt\u2013beta-catenin signaling by Kremen","volume":"1","author":"Cselenyi","year":"2008","journal-title":"Sci Signal"},{"key":"10.1016\/j.blre.2013.08.002_bb0110","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1600-0609.2008.01065.x","article-title":"Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma","volume":"80","author":"Kaiser","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2013.08.002_bb0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood-2008-03-145169","article-title":"The role of Dickkopf-1 in bone development, homeostasis, and disease","volume":"113","author":"Pinzone","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.08.002_bb0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.leukres.2006.04.014","article-title":"Myeloma bone disease: pathogenetic mechanisms and clinical assessment","volume":"31","author":"Silvestris","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2013.08.002_bb0125","doi-asserted-by":"crossref","first-page":"28067","DOI":"10.1074\/jbc.M300373200","article-title":"The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow","volume":"278","author":"Gregory","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2013.08.002_bb0130","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1634\/stemcells.2005-0220","article-title":"A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma","volume":"24","author":"Gunn","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.blre.2013.08.002_bb0135","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.leu.2404621","article-title":"Bone marrow mesenchymal stem cells are abnormal in multiple myeloma","volume":"21","author":"Corre","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2013.08.002_bb0140","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1080\/10428190701593644","article-title":"Mesenchymal stem cell abnormalities in patients with multiple myeloma","volume":"48","author":"Garderet","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2013.08.002_bb0145","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bone.2006.03.017","article-title":"Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia","volume":"39","author":"Li","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.blre.2013.08.002_bb0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood-2008-01-132134","article-title":"Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma","volume":"112","author":"Qiang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.08.002_bb0155","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1182\/blood.V98.13.3527","article-title":"Myeloma cells induce imbalance in the osteoprotegerin\/osteoprotegerin ligand system in the human bone marrow environment","volume":"98","author":"Giuliani","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.08.002_bb0160","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1182\/blood-2010-09-308171","article-title":"Pharmaceutical inhibition of glycogen synthetase kinase-3beta reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model","volume":"117","author":"Gunn","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.08.002_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1196\/annals.1334.010","article-title":"How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow","volume":"1049","author":"Gregory","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.blre.2013.08.002_bb0170","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1359\/jbmr.060311","article-title":"Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass","volume":"21","author":"Morvan","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.blre.2013.08.002_bb0175","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1359\/JBMR.050614","article-title":"Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells","volume":"20","author":"van der Horst","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.blre.2013.08.002_bb0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-4598-6-71","article-title":"Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF","volume":"6","author":"Fujita","year":"2007","journal-title":"Mol Cancer"},{"key":"10.1016\/j.blre.2013.08.002_bb0185","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1158\/0008-5472.CAN-11-2067","article-title":"Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1","volume":"72","author":"Fowler","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2013.08.002_bb0190","doi-asserted-by":"crossref","first-page":"6270s","DOI":"10.1158\/1078-0432.CCR-06-0845","article-title":"New potential targets for treating myeloma bone disease","volume":"12","author":"Roodman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.blre.2013.08.002_bb0195","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bone.2007.12.006","article-title":"Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma","volume":"42","author":"Qiang","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.blre.2013.08.002_bb0200","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1517\/14728220903025770","article-title":"Dickkopf-1: a suitable target for the management of myeloma bone disease","volume":"13","author":"Gavriatopoulou","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.blre.2013.08.002_bb0205","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2141.2006.06356.x","article-title":"Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma","volume":"135","author":"Terpos","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2013.08.002_bb0210","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1158\/0008-5472.CAN-06-4666","article-title":"Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment","volume":"67","author":"Giuliani","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2013.08.002_bb0215","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/ijc.22033","article-title":"Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation","volume":"119","author":"Politou","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2013.08.002_bb0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2141.2007.06871.x","article-title":"Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis","volume":"140","author":"Haaber","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2013.08.002_bb0225","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/leu.2009.129","article-title":"Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma","volume":"23","author":"Durie","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2013.08.002_bb0230","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1158\/1078-0432.CCR-11-0994","article-title":"A gene expression-based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatment","volume":"17","author":"Wu","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.blre.2013.08.002_bb0235","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood-2006-09-047712","article-title":"Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo","volume":"109","author":"Yaccoby","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.08.002_bb0240","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/blood-2008-11-191577","article-title":"Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma","volume":"114","author":"Fulciniti","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.08.002_bb0245","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1359\/jbmr.081104","article-title":"Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma","volume":"24","author":"Heath","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.blre.2013.08.002_bb0250","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bone.2013.01.012","article-title":"In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma","volume":"53","author":"Pozzi","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.blre.2013.08.002_bb0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tibtech.2008.11.007","article-title":"Tipping the balance: modulating the Wnt pathway for tissue repair","volume":"27","author":"Zhao","year":"2009","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.blre.2013.08.002_bb0260","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.seminhematol.2012.04.011","article-title":"Proteasome inhibitors and bone disease","volume":"49","author":"Qiang","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2013.08.002_bb0265","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1182\/blood-2008-08-174300","article-title":"Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin\/TCF signaling","volume":"113","author":"Qiang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.08.002_bb0270","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2141.2007.06829.x","article-title":"Stimulation of new bone formation by the proteasome inhibitor, bortezomib: implications for myeloma bone disease","volume":"139","author":"Oyajobi","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2013.08.002_bb0275","first-page":"278","article-title":"Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation","volume":"90","author":"Patriarca","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2013.08.002_bb0280","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1016\/j.vaccine.2010.06.088","article-title":"Peptide-based immunotherapy for multiple myeloma: current approaches","volume":"28","author":"Zhou","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.blre.2013.08.002_bb0285","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1182\/blood-2007-03-082529","article-title":"Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma","volume":"110","author":"Qian","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2013.08.002_bb0290","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM199508103330607","article-title":"Endothelins","volume":"333","author":"Levin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2013.08.002_bb0295","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.blre.2013.08.002_bb0300","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1210\/me.2006-0346","article-title":"Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation","volume":"21","author":"Clines","year":"2007","journal-title":"Mol Endocrinol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X13000489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X13000489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:47:38Z","timestamp":1715957258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X13000489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0268960X13000489"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2013.08.002","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2013.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}